Transaction in Own Shares, Science Group PLC, 2020-05-06

RNS Number : 0231M
Science Group PLC
06 May 2020



 6 May 2020


Science Group plc

(the “Company” or “Science Group”)


Transaction in own shares


Science Group plc (AIM:SAG) announces that, on 5 May 2020, it purchased 5,000 of its 1 pence ordinary shares at an average price of 190.0 pence per share. The highest price paid per share was 190.0 pence and the lowest price paid per share was 190.0 pence. The Company purchased these shares through Liberum Capital Limited.

The number of shares purchased represented 0.01% of the voting rights attributable to the total ordinary shares in issue prior to the purchase. The purchased shares will be held in treasury.

The total number of ordinary shares in issue (excluding treasury shares) following this announcement is 41,685,440.  Science Group holds 376,595 shares in treasury.  The total number of voting rights in the Company following this announcement is 41,581,040.


The figure of 41,581,040 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company, under the FCA’s Disclosure and Transparency Rules.


Schedule of Purchases – Individual Transactions

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation), the schedule below contains detailed information about the purchases made by Liberum Capital Limited on behalf of the Company as part of the buyback programme.


Number of shares purchased

Transaction price (per share)

Time of transaction

Execution venue






– Ends –




For further information:


Science Group plc

Sarah Cole, Company Secretary

Tel: +44 (0) 1223 875 200


Panmure Gordon (UK) Limited

Nominated Adviser: Dominic Morley/Alina Vaskina

Tel: +44 (0) 20 7886 2500

Corporate Broking: Erik Anderson


Liberum Capital Limited

Tel: +44 (0) 20 3100 2000

Neil Patel/Cameron Duncan/Robert Morton/Ed Phillips


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit




Leave a Reply

Your email address will not be published.